We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Live Cells Detect Food-Borne Pathogens, Toxins

By Labmedica staff writers
Posted on 11 Mar 2008
A new technology can simultaneously screen thousands of samples of food or water for several dangerous food-borne pathogens in one to two hours. More...
The technique also can estimate the amount of microbes present and whether they pose an active health risk. This could help neutralize potential threats and improve food-processing techniques.

The technology utilizes live mammalian cells that release a measurable amount of a signaling chemical when harmed. Optical equipment and computer software then analyze this quantity to estimate the amount of harmful microbes present. The technology can recognize very small amounts of Listeria monocytogenes; a bacterium that kills one in five infected, and is the leading cause of food-borne illness. It also recognizes several species of Bacillus, a non-fatal but common cause of food poisoning.

The cells are suspended in collagen gel, a substance that captures particles of a desired size, and put into small wells within multiwell plates. Each well can test one sample, so tests can be expanded to quickly analyze as many samples as desired. Because the technology tests for bacteria and toxins that attack cell membranes, cells are used with high amounts of alkaline phosphatase, the signaling chemical released upon damage to the cell membrane.

Samples of food and water are added to biosensor wells before being incubated for one to two hours. To each well a chemical is added that reacts with the biosensor's alkaline phosphatase, yielding a yellow product that is quantified by a special camera and a computer.

Actively harmful pathogens are identified whereas those that are inactive or harmless are ignored. Other tests lack this capability, making them prone to false alarms and entailing a relatively lengthy incubation period to culture any living microbes. The new technology's discerning power also could help optimize processes to kill harmful microbes or deactivate toxins.

The technique is versatile, and the multiwell plates and their contents of gel-suspended mammalian cells can be prepared in a central location. When desired, the plates could then be shipped to the test location, such as a food-processing plant, so that on-site analysis could take place.

The suspension of live mammalian cells within a collagen gel is unique, according to the scientists from Purdue University (West Lafayette, IN, USA) who developed the technique, which was described in the February 2008 issue of the journal Laboratory Investigation.


Related Links:
Purdue University

Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
Pipette Calibration System
Artel PCS®
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: The study compares rapid molecular CPE diagnostics, which can return results in about one hour, with culture-based screening, which typically takes about 48 hours (Image credit: Adobe Stock)

Rapid Molecular Screening Aims to Accelerate Hospital Infection Control for CPE

Drug-resistant infections remain a critical patient-safety threat in hospitals, with carbapenemase-producing Enterobacterales (CPE) among the most urgent concerns. In England, reports of acquired carbapenemase... Read more

Industry

view channel
Image: The partnership aims to broaden access to ultrasensitive blood-based testing for multiple myeloma and other hematologic malignancies (Image credit: 123RF)

Partnership Expands Ultrasensitive Blood-Based Diagnostics for Hematologic Malignancies

Predicta Biosciences (Cambridge, MA, USA) and CIMA LAB Diagnostics at Clínica Universidad de Navarra (Pamplona, Spain) have entered an agreement to provide a joint service that combines CIMA LAB’s flow... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.